CORDIS
Resultados de investigaciones de la UE

CORDIS

Español ES

AnThocyanin and polyphenol bioactives for Health Enhancement through Nutritional Advancement

Información del proyecto

Identificador del acuerdo de subvención: 245121

Estado

Proyecto cerrado

  • Fecha de inicio

    1 Julio 2010

  • Fecha de finalización

    30 Junio 2015

Financiado con arreglo a:

FP7-KBBE

  • Presupuesto general:

    € 4 292 680,85

  • Aportación de la UE

    € 2 996 226

Coordinado por:

JOHN INNES CENTRE

Reino Unido

Objetivo

Anthocyanins are health promoting dietary polyphenols that protect against cardiovascular disease, caner and obesity in preclinical studies with animals. The ATHENA project will address how good dietary anthocyanins are in protecting against chronic disease, by addressing the following questions: • Benefits and risks: What is the dose response to anthocyanin phytonutrients? Are anthocyanins from different food sources equivalent? How well do anthocyanins perform in promoting health compared to other polyphenol phytonutrients such as stilbenes, isoflavones and epicatechins? • Mechanisms of action: What are the mechanisms of action of polyphenol phytonutrients in combating chronic diseases? How do anthocyanins limit weight gain/fat development? How do dietary anthocyanins offer cardioprotection? How do dietary anthocyanins slow the progression of cancers? • Food or Pharma: Supplements or extracts of polyphenols do not appear to promote health as well as when they are consumed in whole foods. What is the influence of nutritional context on the efficacy of polyphenol phytonutrients? Does nutritional context influence the bioavailability of polyphenol phytonutrients? • Roles in human: Do dietary anthocyanins afford protection against cardiovascular disease, cancer and other chronic diseases in human? It is the uniqueness of the interactions that ATHENA will promote, that will innovate and give the most significant added-value to Europe. ATHENA will bring together groups with widely different expertise from across Europe, so that the consortium will be able to achieve significant progress towards addressing the Grand Challenge of Chronic Disease. It will impact the health, well being and quality of life across Europe.

Coordinador

JOHN INNES CENTRE

Dirección

Norwich Research Park Colney
Nr4 7uh Norwich

Reino Unido

Tipo de actividad

Research Organisations

Aportación de la UE

€ 388 840

Contacto administrativo

Mary Anderson (Dr.)

Participantes (12)

UNIVERSITE JOSEPH FOURIER GRENOBLE 1

Francia

UNIVERSITA DEGLI STUDI DI MILANO

Italia

Aportación de la UE

€ 509 000

LEIBNIZ - INSTITUT FUER PFLANZENGENETIK UND KULTURPFLANZENFORSCHUNG

Alemania

Aportación de la UE

€ 264 001

UNIVERSITA CATTOLICA DEL SACRO CUORE

Italia

Aportación de la UE

€ 84 319,87

STICHTING WAGENINGEN RESEARCH

Países Bajos

Aportación de la UE

€ 270 000

UNIVERSITE GRENOBLE ALPES

Francia

Aportación de la UE

€ 273 012

ISTANBUL TEKNIK UNIVERSITESI

Turquía

Aportación de la UE

€ 180 158

ISTITUTO EUROPEO DI ONCOLOGIA SRL

Italia

Aportación de la UE

€ 268 800

CONSIGLIO PER LA RICERCA IN AGRICOLTURA E L'ANALISI DELL'ECONOMIA AGRARIA

Italia

Aportación de la UE

€ 116 100

QUADRAM INSTITUTE BIOSCIENCE

Reino Unido

Aportación de la UE

€ 268 500

KOS GENETIC S.R.L.

Italia

Aportación de la UE

€ 157 815

INSTITUTO NEUROLOGICO MEDITERRANEO- NEUROMED SRL

Italia

Aportación de la UE

€ 215 680,13

Información del proyecto

Identificador del acuerdo de subvención: 245121

Estado

Proyecto cerrado

  • Fecha de inicio

    1 Julio 2010

  • Fecha de finalización

    30 Junio 2015

Financiado con arreglo a:

FP7-KBBE

  • Presupuesto general:

    € 4 292 680,85

  • Aportación de la UE

    € 2 996 226

Coordinado por:

JOHN INNES CENTRE

Reino Unido